Pregnancy and Crohn's disease.


Autoria(s): Mottet C.; Juillerat P.; Gonvers J.J.; Froehlich F.; Burnand B.; Vader J.P.; Michetti P.; Felley C.
Data(s)

2005

Resumo

Crohn's disease commonly affects women of childbearing age. Available data on Crohn's disease and pregnancy show that women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby. Control of disease activity before conception and during pregnancy is critical, to optimize both maternal and fetal health. Generally speaking, pharmacological therapy for Crohn's disease during pregnancy is similar to pharmacological therapy for non-pregnant patients. Patients maintained in remission by way of pharmacological therapy should continue it throughout their pregnancy. Most drugs, including sulfasalazine, mesalazine, corticosteroids, and immunosuppressors such as azathioprine and 6-mercaptopurine, are safe, whereas methotrexate is contraindicated.

Identificador

http://serval.unil.ch/?id=serval:BIB_9B417118D447

isbn:0012-2823

pmid:15711051

doi:10.1159/000083874

isiid:000227888500012

Idioma(s)

en

Fonte

Digestion, vol. 71, no. 1, pp. 54-61

Palavras-Chave #Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Mesalamine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Safety
Tipo

info:eu-repo/semantics/review

article